Dr. Ginevra Friggeri graduated in Biotechnology for Personalized Medicine at Università Cattolica del Sacro Cuore. She has then participate as collaborator for the project “Sars-on-chip – develop of Lab-on-chip with lipid nanoparticles for the quantification of the Sars-CoV-2 viral load from nasal swab.” Her interest are focus in the field of Biophysics and Nanomedicine applied in the cancer research. She now fill the role of Institute Technician at the Scientific Direction — Facility 3D Bioprinting at Fondazione Policlinico Gemelli, where she works as a researcher in the biomedical field; she is involved in the research and discover of new biocompatible Nanomaterials and the use of 3D bioprinting technics to reproduce reliable models to find new cures against the cancer and many other diseases.